Zobrazeno 1 - 2
of 2
pro vyhledávání: '"Vikki L Field"'
Autor:
Cherie L. Butts, Aymen Al-Shamkhani, Ann L. White, Ruth R. French, Mark S. Cragg, Emily L Williams, Stephen A. Beers, Peter Johnson, Martin J. Glennie, Elizabeth A. Potter, J. Sjef Verbeek, Lang Dou, Steven G. Booth, C. Ian Mockridge, Kane Moss, Vikki L Field, H.T. Claude Chan
Publikováno v:
Journal of Immunology, 193(4), 1828-1835
Immunomodulatory mAbs, led by the anti-CTLA4 mAb ipilimumab, are an exciting new class of drugs capable of promoting anticancer immunity and providing durable control of some tumors. Close analysis of a number of agents has revealed a critical yet va
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f8e82a207940b88f0c8c8e92783ded68
https://hdl.handle.net/1887/104737
https://hdl.handle.net/1887/104737
Autor:
Martin J. Glennie, Claude H.T. Chan, Tibor Keler, Peter M Johnson, Kerry L. Cox, Vikki L Field, Sean H. Lim, Sonya James, Mark S. Cragg, Anna H. Turaj, Christine A. Penfold, Jinny Kim, Aymen Al-Shamkhani, Stephen A. Beers
Publikováno v:
Blood. 128:3024-3024
Direct-targeting monoclonal antibodies (mAb) such as anti-CD20 mAb are thought to elicit their anti-tumor function through antibody-dependent cellular phagocytosis (ADCP) mediated by myeloid cells (monocytes and macrophages), with little involvement
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::bedb4c383ef34d8886002d042962ee55
https://doi.org/10.1182/blood.v128.22.3024.3024
https://doi.org/10.1182/blood.v128.22.3024.3024
